Mitsubishi acquiring NeuroDerm

Mitsubishi Tanabe Pharma Corp. (Tokyo:4508) will acquire neurology company NeuroDerm Ltd. (NASDAQ:NDRM) for $1.1 billion at a price of $39

Read the full 203 word article

How to gain access

Continue reading with a
two-week free trial.